Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study - PubMed (original) (raw)
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study
B C Martin et al. Lancet. 1992.
Abstract
Type 2 diabetes mellitus is characterised by resistance of peripheral tissues to insulin and a relative deficiency of insulin secretion. To find out which is the earliest or primary determinant of disease, we used a minimum model of glucose disposal and insulin secretion based on intravenous glucose tolerance tests to estimate insulin sensitivity (SI), glucose effectiveness (ie, insulin-independent glucose removal rate, SG), and first-phase and second-phase beta-cell responsiveness in normoglycaemic offspring of couples who both had type 2 diabetes. 155 subjects from 86 families were followed-up for 6-25 years. More than 10 years before the development of diabetes, subjects who developed the disease had lower values of both SI (mean 3.2 [SD 2.4] vs 8.1 [6.7] 10(-3) I min-1 pmol-1 insulin; p < 0.0001) and SG (1.6 [0.9] vs 2.3 [1.2] 10(-2) min-1, p < 0.0001) than did those who remained normoglycaemic). For the subjects with both SI and SG below the group median, the cumulative incidence of type 2 diabetes during the 25 years was 76% (95% confidence interval 54-99). By contrast, no subject with both SI and SG above the median developed the disease. Subjects with low SI/high SG or high SI/low SG had intermediate risks. Insulin secretion, especially first phase, tended to be increased rather than decreased in this prediabetic phase and was appropriate for the level of insulin resistance. The development of type 2 diabetes is preceded by and predicted by defects in both insulin-dependent and insulin-independent glucose uptake; the defects are detectable when the patients are normoglycaemic and in most cases more than a decade before diagnosis of disease.
Comment in
- Role of glucose and insulin resistance in development of type 2 diabetes mellitus.
Godsland IF, Walton C, Wynn V. Godsland IF, et al. Lancet. 1992 Nov 28;340(8831):1347-8. doi: 10.1016/0140-6736(92)92527-m. Lancet. 1992. PMID: 1360052 No abstract available. - Role of glucose and insulin resistance in development of type 2 diabetes mellitus.
Kumar S, Boulton A, Hosker J. Kumar S, et al. Lancet. 1992 Nov 28;340(8831):1348. Lancet. 1992. PMID: 1360053 No abstract available.
Similar articles
- Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM.
Coates PA, Ollerton RL, Luzio SD, Ismail IS, Owens DR. Coates PA, et al. Diabetes. 1993 Nov;42(11):1635-41. doi: 10.2337/diab.42.11.1635. Diabetes. 1993. PMID: 8405706 - Familial clustering of insulin sensitivity.
Martin BC, Warram JH, Rosner B, Rich SS, Soeldner JS, Krolewski AS. Martin BC, et al. Diabetes. 1992 Jul;41(7):850-4. doi: 10.2337/diab.41.7.850. Diabetes. 1992. PMID: 1612199 - Decreased glucose effectiveness but not insulin resistance in glucose-tolerant offspring of Japanese non-insulin-dependent diabetic patients: a minimal-model analysis.
Doi K, Taniguchi A, Nakai Y, Kawamura H, Higaki Y, Yokoi H, Tanaka H, Fujitani J, Suzuki M, Tokuyama K, Sakai M, Fukushima M. Doi K, et al. Metabolism. 1997 Aug;46(8):880-3. doi: 10.1016/s0026-0495(97)90073-1. Metabolism. 1997. PMID: 9258268 - Glucose metabolism in patients with psoriasis.
Friis NU, Hoffmann N, Gyldenløve M, Skov L, Vilsbøll T, Knop FK, Storgaard H. Friis NU, et al. Br J Dermatol. 2019 Feb;180(2):264-271. doi: 10.1111/bjd.17349. Epub 2018 Dec 13. Br J Dermatol. 2019. PMID: 30376181 Review.
Cited by
- Non-linear relationship between TyG index and the risk of prediabetes in young people: a 5-year retrospective cohort study in Chinese young adults.
Xiao J, Zhou L, Luo C, Han Y, Huang Z. Xiao J, et al. Front Endocrinol (Lausanne). 2024 Aug 16;15:1414402. doi: 10.3389/fendo.2024.1414402. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39220362 Free PMC article. - A single-center retrospective study on the clinical features of thyrotoxic periodic paralysis.
Yamada K, Tanabe A, Hashimoto M, Ohsugi M, Ueki K, Kajio H. Yamada K, et al. PLoS One. 2024 Aug 1;19(8):e0308076. doi: 10.1371/journal.pone.0308076. eCollection 2024. PLoS One. 2024. PMID: 39088436 Free PMC article. - Ethnicity-related differences in mitochondrial regulation by insulin stimulation in diabetes.
Neikirk K, Kabugi K, Mungai M, Kula B, Smith N, Hinton AO Jr. Neikirk K, et al. J Cell Physiol. 2024 Aug;239(8):e31317. doi: 10.1002/jcp.31317. Epub 2024 May 22. J Cell Physiol. 2024. PMID: 38775168 Review. - Metformin and the Liver: Unlocking the Full Therapeutic Potential.
Perazza F, Leoni L, Colosimo S, Musio A, Bocedi G, D'Avino M, Agnelli G, Nicastri A, Rossetti C, Sacilotto F, Marchesini G, Petroni ML, Ravaioli F. Perazza F, et al. Metabolites. 2024 Mar 25;14(4):186. doi: 10.3390/metabo14040186. Metabolites. 2024. PMID: 38668314 Free PMC article. Review. - The Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study.
Satpathy S, Panigrahi LL, Arakha M. Satpathy S, et al. Curr Top Med Chem. 2024;24(15):1327-1342. doi: 10.2174/0115680266299494240326083936. Curr Top Med Chem. 2024. PMID: 38561614 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous